Co-expression of erbB3 and erbB2 is frequently observed in breast cancers [12] and breast cancer cell lines [13], and erbB3 plays an important role in breast cancer development driven by erbB2 amplification/overexpression [14]. This evidence concerns the gene ERBB3 and breast carcinoma.